At least 10 biopharma companies have notable layoffs since the beginning of the month.
Tag Archive for: REGENXBIO
The nonprofit biotech Cure Rare Disease (CRD) is headed to the clinic with a CRISPR therapeutic aimed at halting the progression of Duchenne muscular dystrophy in single-patient dosing.